Kiniksa Pharmaceuticals International (KNSA) Share-based Compensation Growth (3y) (2020 - 2026)
Kiniksa Pharmaceuticals International (KNSA) Share-based Compensation Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Kiniksa Pharmaceuticals International | 6.14 Bn | 5.61 Bn | 220.03 Mn | 319.16% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 319.16% |
| Mar 31, 2026 | 381.65% |
| Dec 31, 2025 | 17.11% |
| Sep 30, 2025 | 154.13% |
| Jun 30, 2025 | 153.94% |
| Mar 31, 2025 | 163.60% |
| Dec 31, 2024 | 10.62% |
| Sep 30, 2024 | 8.08% |
| Jun 30, 2024 | -30.07% |
| Mar 31, 2024 | 48.38% |
| Dec 31, 2023 | 7.50% |
| Sep 30, 2023 | 6.89% |
| Jun 30, 2023 | -68.06% |
| Mar 31, 2023 | -72.24% |
| Dec 31, 2022 | 8.67% |
| Sep 30, 2022 | 17.14% |
| Jun 30, 2022 | -46.11% |
| Mar 31, 2022 | -47.32% |
| Dec 31, 2021 | 33.41% |
| Sep 30, 2021 | 60.40% |